Last reviewed · How we verify

NCT06091722

Quantitative Assessment of Lid Margin Vascularity Using SS-OCTA

Status unknown Last updated 19 October 2023
What this trial tests

trial in Ss-octa in 150 participants. Status unknown.

Timeline
20 October 2023
Primary endpoint
1 December 2023
28 February 2024

Quick facts

Lead sponsorWenzhou Medical University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment150
Start date20 October 2023
Primary completion1 December 2023
Estimated completion28 February 2024

Conditions studied

Sponsor

Wenzhou Medical University

Who can join

20 and older, any sex, with Ss-octa or Lid Margin Blood Flow Density. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To explore an optimized scan technique for the detection of lid margin vasculature

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Quantitative Assessment of Lid Margin Vascularity Using Swept-Source Optical Coherence Tomography Angiography.
    Hu M, Wang C, Li Y, Zhang H, et al · · 2024 · cited 1× · PMID 38874976 · DOI 10.1167/tvst.13.6.6

Verify or expand the search:

Other Wenzhou Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06091722.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing